XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Operating activities:    
Net income (loss) $ 235,539 $ (1,216,259)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 292,842 403,430
Stock-based compensation 10,612 15,069
Non-cash life insurance policy reduction / (accretion) 19,162
Non-cash other revenue (172,866)
Non-cash miscellaneous loss 24,618
(Gain) loss on sale of property, plant and equipment (434,549) (2,838)
Foreign currency transaction (gain) loss 1,149 (194)
(Increase) decrease in trade, accounts & notes receivable, and deposits from related parties (715,018) (180,145)
(Increase) decrease in inventories 758,798 415,760
(Increase) decrease in refundable income taxes (3,295) 3,616
(Increase) decrease in prepaid expenses and other current assets (295,925) (274,252)
(Increase) decrease in other assets (68,807) (948)
Increase (decrease) in income taxes payable 16,148 (6,930)
Increase (decrease) in accounts payable & accrued expenses, deferred revenue, and other noncurrent liabilities (293,111) 568,291
Net cash used in operating activities (643,865) (256,238)
Investing activities:    
Purchase of property, plant and equipment (50,180) (56,968)
Proceeds from the sale of property, plant and equipment 3,888
Payments received on notes receivables - related parties 109,984 57,079
Net cash provided by investing activities 59,804 3,999
Financing activities:    
Proceeds from line of credit borrowings 500,000
Principal payments on long-term borrowings (189,560)
Net cash provided by (used in) financing activities 500,000 (189,560)
Effect of exchange rate changes on cash and cash equivalents 12,808 (66,901)
Increase (decrease) in cash and cash equivalents (71,253) (508,700)
Cash and cash equivalents at beginning of period 1,989,974 3,272,788
Cash and cash equivalents at end of period $ 1,918,721 $ 2,764,088